Diagnostischer Wert des monoklonalen Antikörpers TTF-1 bei ZNS-Metastasen

[1]  R. Warnick,et al.  Determination of lung as the primary site of cerebral metastatic adenocarcinomas using monoclonal antibody to thyroid transcription factor-1 , 1998, Journal of Neuro-Oncology.

[2]  Roman Kodet,et al.  Value of thyroid transcription factor-1 and surfactant apoprotein A in the differential diagnosis of pulmonary carcinomas: a study of 109 cases , 2002, Virchows Archiv.

[3]  N. Ordóñez.  Value of Thyroid Transcription Factor-1 Immunostaining in Distinguishing Small Cell Lung Carcinomas From Other Small Cell Carcinomas , 2000, The American journal of surgical pathology.

[4]  Dietel,et al.  Expression of thyroid transcription factor‐1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites , 2000, Histopathology.

[5]  J. Whitsett,et al.  Utility of surfactant protein B precursor and thyroid transcription factor 1 in differentiating adenocarcinoma of the lung from malignant mesothelioma. , 1999, Human pathology.

[6]  J. Parisi,et al.  Metastatic adenocarcinoma to the brain: an immunohistochemical approach. , 1997, Human pathology.

[7]  R. Lauro,et al.  Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas. , 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[8]  J. Whitsett,et al.  Monoclonal antibody to thyroid transcription factor-1: production, characterization, and usefulness in tumor diagnosis. , 1996, Hybridoma.

[9]  R. Lauro,et al.  The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain. , 1991, Development.

[10]  G. Krol,et al.  Distribution of brain metastases. , 1988, Archives of neurology.

[11]  A. Leong,et al.  The contribution of immunohistochemical staining in tumour diagnosis , 1987, Histopathology.